This ‘memory effect’ has already been shown in hematological and epithelial tumor cells by [7] and [5] and demonstrates the clinical potential of DNMT inhibition: it might be sufficient to administer this drug for only a short time to achieve a durable effect on the tumor. Here, DNMT1 is linked to neoplasm.